These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9806097)

  • 21. Sertraline for Klüver-Bucy syndrome in an adolescent.
    Mendhekar DN; Duggal HS
    Eur Psychiatry; 2005 Jun; 20(4):355-6. PubMed ID: 16018931
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.
    Serebruany VL; Suckow RF; Cooper TB; O'Connor CM; Malinin AI; Krishnan KR; van Zyl LT; Lekht V; Glassman AH;
    Am J Psychiatry; 2005 Jun; 162(6):1165-70. PubMed ID: 15932816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.
    Reis M; Aberg-Wistedt A; Agren H; Höglund P; Akerblad AC; Bengtsson F
    Hum Psychopharmacol; 2004 Jul; 19(5):283-91. PubMed ID: 15252820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline.
    Spina E; Avenoso A; Salemi M; Facciolá G; Scordo MG; Ancione M; Madia A
    Pharmacopsychiatry; 2000 Nov; 33(6):213-7. PubMed ID: 11147928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of trazodone to sertraline: a probable synergistic action in a case of obsessive-compulsive disorder.
    Rocha FF; Corrêa H; Lage NV
    Braz J Psychiatry; 2007 Dec; 29(4):381-2. PubMed ID: 18200402
    [No Abstract]   [Full Text] [Related]  

  • 26. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
    Gaynes BN; Farley JF; Dusetzina SB; Ellis AR; Hansen RA; Miller WC; Stürmer T
    Depress Anxiety; 2011 Nov; 28(11):989-98. PubMed ID: 21898717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open-label trial.
    Huang X; Li C; Li WH; Luo YL; Wang B; Zhang W; Gan JJ; Ji JL
    Hum Psychopharmacol; 2013 Nov; 28(6):594-9. PubMed ID: 24519693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.
    Lass-Flörl C; Dierich MP; Fuchs D; Semenitz E; Ledochowski M
    Clin Infect Dis; 2001 Dec; 33(12):E135-6. PubMed ID: 11700578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs.
    Epperson N; Czarkowski KA; Ward-O'Brien D; Weiss E; Gueorguieva R; Jatlow P; Anderson GM
    Am J Psychiatry; 2001 Oct; 158(10):1631-7. PubMed ID: 11578995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant reduction of sertraline plasma levels by carbamazepine and phenytoin.
    Pihlsgård M; Eliasson E
    Eur J Clin Pharmacol; 2002 Feb; 57(12):915-6. PubMed ID: 11936714
    [No Abstract]   [Full Text] [Related]  

  • 32. Sertraline and breastfeeding: review and meta-analysis.
    Pinheiro E; Bogen DL; Hoxha D; Ciolino JD; Wisner KL
    Arch Womens Ment Health; 2015 Apr; 18(2):139-146. PubMed ID: 25589155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.
    Kaddurah-Daouk R; Boyle SH; Matson W; Sharma S; Matson S; Zhu H; Bogdanov MB; Churchill E; Krishnan RR; Rush AJ; Pickering E; Delnomdedieu M
    Transl Psychiatry; 2011; 1(7):e26-. PubMed ID: 22162828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder.
    Abbas S; Chandra PS; Srivastava M
    J Clin Psychiatry; 1995 Oct; 56(10):484. PubMed ID: 7559376
    [No Abstract]   [Full Text] [Related]  

  • 35. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    Poyurovsky M; Kurs R; Weizman A
    J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
    [No Abstract]   [Full Text] [Related]  

  • 36. Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline.
    Markowitz JS; DeVane CL
    J Clin Psychopharmacol; 2000 Feb; 20(1):109-10. PubMed ID: 10653222
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective serotonin reuptake inhibitors for migraine prophylaxis.
    Landy S; McGinnis J; Curlin D; Laizure SC
    Headache; 1999 Jan; 39(1):28-32. PubMed ID: 15613191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early augmentation of sertraline with methylphenidate.
    Postolache TT; Rosenthal RN; Hellerstein DJ; Aromin R; Kelton GM; Muran JC; Londono JH
    J Clin Psychiatry; 1999 Feb; 60(2):123-4. PubMed ID: 10084641
    [No Abstract]   [Full Text] [Related]  

  • 39. Serotonin syndrome with ziprasidone and sertraline.
    Palekar N; Eisman J
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E1. PubMed ID: 23686039
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clozapine and selective serotonin reuptake inhibitors: risks of toxicity].
    Michielsen PJ; Thunnissen MM; Van Den Bossche B
    Tijdschr Psychiatr; 2007; 49(9):655-9. PubMed ID: 17853375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.